Symbol: |
SPAST
|
Description: |
spastin [Source:HGNC Symbol;Acc:11233]
|
Location: |
Chr2:32288680-32382706[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:199
Gene |
Compound |
Gen_sig |
Exp_pattern |
SPAST |
NSC 109834 |
0.027 |
Down |
SPAST |
NSC 116878 |
0.016 |
Down |
SPAST |
NSC 117198 |
0.02 |
Down |
SPAST |
D-Amethopterin |
0.007 |
Down |
SPAST |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.021 |
Down |
SPAST |
NSC 123978 |
0.048 |
Down |
SPAST |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.028 |
Down |
SPAST |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.03 |
Down |
SPAST |
EUPACUNIN |
0.042 |
Down |
SPAST |
Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) |
0.035 |
Down |
SPAST |
TZT |
0.009 |
Down |
SPAST |
as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- |
0.009 |
Down |
SPAST |
NSC 148201 |
0.009 |
Down |
SPAST |
Phosphinic amide, P,P-bis(1-aziridinyl)-N-tricyclo[3.3.1.1(3.7)]dec-1-yl- |
0.028 |
Down |
SPAST |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.022 |
Down |
Expression pattern: Sensitivity / Resistance
Total:14 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
|
miRNA:
~ Export ~
|
Records:2
Gene |
Gen_transcript |
miRNA |
miR_location |
SPAST |
ENST00000315285 |
hsa-mir-132-5p |
Chr17:1953259-1953280[-] |
SPAST |
ENST00000315285 |
hsa-mir-421 |
ChrX:73438227-73438249[-] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|